REG - Induction Healthcare - Block listing Interim Review

Induction HealthcareAnnouncement

31/07/2023 15:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230731:nRSe7796Ha&default-theme=true

RNS Number : 7796H  Induction Healthcare Group PLC   31 July 2023

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Block Listing Six Monthly Return

 

Induction Healthcare (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems, makes the six monthly update on its
block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for
Companies below. The Company has identified an error in the six monthly update
to 26 July 2022, announced on 27 July 2022, which incorrectly detailed 396,567
ordinary shares as having been issued and allotted when it should have been
329,573 ordinary shares.  As such, the number of ordinary shares still to be
issued and allotted is 3,170,427 and not 3,103,433 as previously incorrectly
disclosed.

 

 Name of applicant:                                                                Induction Healthcare Group PLC

                                                                                   LEI: 213800RY96GCZQW5TP19

 Name of scheme:                                                                   The Induction Healthcare NTA Share Option Plan

 Period of return:                                                                  From:        27/01/2023    To:           26/07/2023

 Number and class of securities originally admitted and the date of admission      3,500,000 ordinary shares on 26 July 2021

 Balance of unallotted securities under scheme(s) from initial application:        3,170,427

 Plus: The amount by which the block scheme(s) has been increased since the        Nil
 date of the last return (if any increase has been applied for):

 Less: Number of securities issued/allotted under scheme(s) during the period:     Nil

 Equals: Balance under scheme(s) not yet issued/allotted at end of period:         3,170,427

 Contact:                                                                          Louise Torr, Company Secretary

                                                                                   louise.t@inductionhealthcare.com

 

Enquiries

 

 Induction

 Christopher Samler, Chair                              +44 (0)7712 194092

 Paul Tambeau, Chief Executive Officer                  +44 (0)7983 104443

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0)20 7496 3000
 Philip Davies

 

 

About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) Induction delivers a suite of software solutions that
transforms care delivery and the patient journey through hospital. Our
system-wide applications help healthcare providers and administrators to
deliver care at any stage remotely as well as face-to-face - giving the
communities they serve greater flexibility, control and ease of access.
Purpose-built for integration with leading Electronic Medical Record (EMR)
platforms, our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRWPUBUMUPWGCG